Zhengye Biotechnology Holding Limited (ZYBT)

CN — Healthcare Sector
Peers: IXHL  SXTC  CTOR  MOLN  RCEL  SPRO  MBOT  LNSR  GLSI  ATOS 

Automate Your Wheel Strategy on ZYBT

With Tiblio's Option Bot, you can configure your own wheel strategy including ZYBT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ZYBT
  • Rev/Share 0.0
  • Book/Share 0.0
  • PB 0.0
  • Debt/Equity 0.3044
  • CurrentRatio 1.3065
  • ROIC 0.035

 

  • MktCap 854588540.0775
  • FreeCF/Share 0.0
  • PFCF 64.3855
  • PE 0.0
  • Debt/Assets 0.1752
  • DivYield 0
  • ROE 0.0406

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Zhengye Biotechnology Holding Limited (ZYBT)

  • IPO Date 2025-01-07
  • Website https://www.jlzybio.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Songlin Song
  • Employees 278
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.